Applied Spectral Imaging and KromaTiD announce strategic partnership
LONGMONT/CARLSBAD, Calif. -- KromaTiD and California-based Applied Spectral Imaging (ASI) announced they have entered into a strategic commercial partnership, granting ASI worldwide rights to... Read More
Friday April 9, 2021 0 comments
KromaTiD announces addition of James Chomas to board of directors
LONGMONT -- KromaTiD announced Colorado biomedical entrepreneur James Chomas has joined the company's board of directors. Chomas has a track record of developing innovative healthcare... Read More
Friday February 12, 2021 0 comments
KromaTiD announces appointment of Vic Myer to board of directors
LONGMONT -- KromaTiD, Inc. announced the appointment of Vic Myer to its board of directors. Myer joins KromaTiD's board with extensive experience in technology, RD and pharmaceutical company... Read More
Wednesday September 23, 2020 0 comments
KromaTiD awarded Direct to Phase II SBIR grant by the National Human Genome Research Institute
LONGMONT -- KromaTiD, Inc. today announced it has been awarded a Direct to Phase II SBIR grant by the National Human Genome Research Institute. The award supports development of a structural... Read More
Monday August 24, 2020 0 comments
KromaTiD announces launch of dGH In-Site
LONGMONT -- KromaTiD, Inc. announced the launch of its new productdGH In-Site, a single-cell, high resolution, genome-wide DNA insert tracking assay. dGH In-Site enables researchers to directly... Read More
Wednesday June 10, 2020 0 comments
KromaTiD announces successful conclusion of Series A funding round
DENVER -- KromaTiD, Inc. announced it successfully completed its A round of financing withDenver-based firm First Capital Ventures. KromaTiD said its traction and potential within the... Read More
Wednesday August 14, 2019 0 comments
KromaTiD appoints Christopher Tompkins new company chief executive
LONGMONT -- KromaTiD, Inc. announced the appointment of Christopher Tompkins as CEO. Tompkins, who joined the company in 2010, most recently served as president, GM and chief technology... Read More
Wednesday June 26, 2019 0 comments
KromaTiD receives $900K in funding from Human Genome Research Institute
FORT COLLINS-- KromaTiD, Inc . announced that after successfully meeting Phase 1 grant milestones, the company has been awarded Phase 2 funding from a Fast Track Small Business Innovation... Read More
Wednesday April 24, 2019 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
